NCT02559115View on ClinicalTrials.gov

68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

September 21, 2015

Primary Completion Date

June 18, 2020

Study Completion Date

June 18, 2020

Conditions
Prostate Cancer
Interventions
RADIATION

68Ga-RM2 (RM2)

DEVICE

PET/CT Scan

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02559115 - 68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer | Biotech Hunter | Biotech Hunter